Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 085517
Company: ABBOTT
Company: ABBOTT
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
A-POXIDE | CHLORDIAZEPOXIDE HYDROCHLORIDE | 5MG | CAPSULE;ORAL | Discontinued | None | No | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
07/01/1977 | ORIG-1 | Approval |
Label is not available on this site. |
Supplements
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
---|---|---|---|---|---|
01/25/1984 | SUPPL-9 | Manufacturing (CMC) |
Label is not available on this site. |
||
03/31/1982 | SUPPL-7 | Manufacturing (CMC) |
Label is not available on this site. |
||
03/31/1982 | SUPPL-6 | Manufacturing (CMC) |
Label is not available on this site. |